Article
Int J Cancer  (2009)

HER3 is required for the maintenance of neuregulin-dependent and -independent attributes of malignant progression in prostate cancer cells

Soler M, Mancini F, Meca-Cortes O, Sanchez-Cid L, Rubio N, Lopez-Fernandez S, Lozano JJ, Blanco J, Fernandez PL, Thomson TM